| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |